Normal view MARC view ISBD view

Cost-effectiveness of PCSK9 Inhibitor Therapy-Reply.

Kazi, Dhruv S

Cost-effectiveness of PCSK9 Inhibitor Therapy-Reply. [electronic resource] - JAMA Nov 2016 - 2152 p. digital

Publication Type: Letter; Comment

ISSN: 1538-3598

Standard No.: 10.1001/jama.2016.16292 doi

Subjects--Topical Terms:
Cost-Benefit Analysis
Humans
Proprotein Convertases
Serine Endopeptidases

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)